We provide pure and potent ingredients to our customers, backed by human clinical trials that have been presented at some of the most distinguished professional scientific meetings. Using the best science available, we have proven our products work and are safe.
ADAIR ASSOCIATES, Inc [PHARMACEUTICAL CONSULTING]
Dennis Adair, Pharma. D., Ph.D. and Suzanne Adair, Ph.D., bring 89 years of technical, regulatory and quality con- sulting services to the pharmaceutical and biotechnology industries. In general, they specialize in technical product development, technology assessment and technology transfer. They have specific expertise in active substance devel- opment, formulation development and process scale-up, quality specifications and analytical development, packaging development, site and facility audits, and production start-up for a wide variety of dosage forms. They hold no financial interest in Nutra Products Inc.
→ click here for more information about Dennis Adair
→ click here for more information about Suzanne Adair
REVIEW & SUMMARY OF CLINICAL TRIALS OF PROPRIETARY PRODUCT
Experimental Biology | April 2008
American College of Nutrition | October 2009
→ click here to read clinical trial
American College of Nutrition | October 2009
→ click here to read clinical trial
CONCLUSION: Evaluations of the plasma curves which clearly indicate that the Fast C product released ascorbic acid for absorption from the GI tract very quickly after dosing, with significant plasma levels obtained at 30 minutes post dose as compared to Ester C. The Fast C formulations consistently appear to produce higher (Cmax) and earlier peak plasma levels (Tmax), compared to the Ester C control product. The Fast C area under the 0-4 hr. plasma curve (AUC0-4) also strongly suggests that more vitamin C has been absorbed and available to the body in the first 4 hours after administration of Fast C, due to a much quicker onset and rate of absorption. The 24 hour urinary excretion data indicate that all the tested Vitamin C products yielded similar total amounts of ascorbic acid absorbed.
→ click here to read entire clinical review
REVIEW & SUMMARY OF CLINICAL TRIAL OF ALKEMY™ VS GATORADE© IN EXERCISE INDUCED DEHYDRATION
American College of Sports Medicine | May 2008
Official Journal of the American College of Sports Medicine, Vol. 40, No. 5, S87
→ click here to read clinical trial
Official Journal of the American College of Sports Medicine, Vol. 40, No. 5, S87
→ click here to read clinical trial
CONCLUSION: The Alkemy product was found to be equal in hydrating power to Gatorade©, in all the physical and physiological parameters studied, following exercise induced dehydration under carefully controlled conditions. Subject comments favored the Alkemy™ product over Gatorade© in terms of taste preference and statements of feeling ‘over full’.
→ click here to read entire clinical review
INFLUENCE OF A BUFFERED MATRIX AND PROTEIN UPON ALLICIN BIOAVAILABILITY FROM A COMMERCIAL GARLIC POWDER
COMPARISON OF COMFORTEZE® AND SEVERAL COMMERCIAL ANTACID PRODUCTS BY A SERIES OF IN VITRO STUDIES OF ACID NEUTRALIZING METHODS
